To the editor, Allergic rhinitis (AR) is a common disease resulting in nasal, ocular and potentially oropharyngeal symptoms. 1 Up to 70% of pollen allergy patients also suffer from the "oral allergy syndrome" (OAS), manifesting in itching and swelling of the oropharynx. 2 Antihistamines are the first choice of drugs to treat allergic oropharyngeal symptoms, but reservation against use of drugs and side effects may limit patient compliance. 1 In addition to pharmacotherapies against AR, guidelines recommend allergen-specific immunotherapy (SIT), comprising subcutaneous (SCIT) or sublingual (SLIT) forms. 3 However, in more than 50% of patients, SLIT preparations cause side effects, resulting in oropharyngeal itching, swelling, discomfort or irritation. 4 These side effects often begin upon initiation of SLIT and This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.